Time-Restricted Eating Helps to Improve Diabetes Outcomes
By Lori Solomon HealthDay Reporter
FRIDAY, Sept. 13, 2024 -- Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study presented at the annual meeting of the European Association for the Study of Diabetes, held from Sept. 9 to 13 in Madrid.
K.A. Bowden Davies, from Manchester Metropolitan University in the United Kingdom, and colleagues examined the effects of TRE in a eucaloric manner, comparing early (ETRE; 8:00-16:00 hours) versus late (LTRE; 12:00-20:00 hours) conditions on habitual (free)-living glycemic control in 15 overweight sedentary adults. In the crossover study, each phase lasted three days.
The researchers found that compared with habitual eating (>14 hours/day), TRE (eight hours/day) significantly increased time spent in euglycemia by 3.3 percent (P < 0.001) and reduced mean absolute glucose by 0.6 mmol/L (P = 0.003), coefficient of variation by 2.6 percent (P < 0.001), and mean amplitude of glucose excursions by 0.4 mmol/L (P = 0.020). There was no significant effect for ETRE versus LTRE (P > 0.05). Habitual calorie intake and macronutrient composition were similar to TRE (P > 0.05).
“Our findings, which can be attributed to the 16-hour fasting window rather than the time of eating or changes in energy intake, highlight the benefit of TRE in only three days,” the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Hyperinsulinemia Linked to Abnormal Uterine Bleeding
TUESDAY, June 10, 2025 -- In premenopausal women, hyperinsulinemia is associated with abnormal uterine bleeding (AUB), with body mass index (BMI) playing a role in this...
Increasing Proportion of U.S. Adults Unaware They Have Hypertension
MONDAY, June 9, 2025 -- From 2013 to 2023, there was an increase in the proportion of U.S. adults who were unaware of having hypertension, according to a research letter published...
Finerenone + Empagliflozin Offers Greater Benefit in CKD, T2DM
MONDAY, June 9, 2025 -- For patients with chronic kidney disease and type 2 diabetes, combination finerenone plus empagliflozin leads to a greater reduction in the urinary...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.